Recent developments in human cytomegalovirus diagnosis

References

• Staras SAS, Dollard SC, Radford KW, Flanders WD, Pass RF, Cannon MJ. Seroprevalence of cytomegalovirus infection in the United States, 1988–1994. Clin. Infect. Dis.43, 1143–1151 (2006).
   PubMed Web of Science ®Google Scholar
• Ho M. Cytomegalovirus, Biology and Infection. Plenum Medical Book Company, NY, USA (1991).
   Google Scholar
• Chan G, Hemmings DG, Yurochko AD, Guilbert LJ. Human cytomegalovirus-caused damage to placental trophoblasts mediated by immediate-early gene-induced tumor necrosis factor-α. Am. J. Pathol.161, 1371–1381 (2002).
   PubMed Web of Science ®Google Scholar
• Calquist JF, Edelman L, Bennion DW, Anderson JL. Cytomegalovirus induction of interleukin-6 in lung fibroblasts occurs independently of active infection and involves a G protein and the transcription factor, NF-κB. J. Infect. Dis.179, 1094–1100 (1999).
   PubMedGoogle Scholar
• Halwachs-Baumann G, Weihrauch G, Gruber HJ, Desoye G, Sinzger CH. hCMV induced IL-6 release in trophoblast and trophoblast like cells. J. Clin. Virol.37, 91–97 (2006).
   PubMedGoogle Scholar
• Halwachs-Baumann G. The congenital cytomegalobirus infection: virus–host interaction for defense and transmission. Curr. Pharm. Biotechnol.7(4), 303–312 (2006).
   PubMed Web of Science ®Google Scholar
• Snydman DR. Epidemiology of infections after solid-organ transplantation. Clin. Infect. Dis.33(Suppl. 1), S5–S8 (2001).
   PubMed Web of Science ®Google Scholar
• Kramer MR, Marshall SE, Starnes VA, Gamberg P, Amitai Z, Theodore J. Infectious complications in heart-lung transplantation. Analysis of 200 episodes. Arch. Intern. Med.153(17), 2010–2016 (1993).
   PubMedGoogle Scholar
• Snydman DR. Infection in solid organ transplantation. Transpl. Infect. Dis.1(1), 21–28 (1999).
   PubMedGoogle Scholar
• Kotloff RM, Ahya VN, Crawford SW. Pulmonary complications of solid organ and hematopoietic stem cell transplantation. Am. J. Respir. Crit. Care Med.170, 22–48 (2004).
   PubMed Web of Science ®Google Scholar
• Falagas ME, Vardakas KZ. Anti-cytomegalovirus prophylaxis in solid-organ transplant recipients. Clin. Microbiol. Infect.12, 603–605 (2006).
   PubMedGoogle Scholar
• Ljungman P, Griffiths P. Definitions of cytomegalovirus infection and disease. In: Multidisciplinary Approach to Understanding Cytomegalovirus Disease. Michelson S, Plotkin SA (Eds). Excerpta Medica, Amsterdam, The Netherlands 233–237 (1993).
   Google Scholar
• Singh N. Cytomegalovirus infection in solid organ transplant recipients: new challenges and their implications for preventive strategies. J. Clin. Virol.35, 474–477 (2006).
   PubMed Web of Science ®Google Scholar
• van der Bij W, Speich R. Management of cytomegalovirus infection and disease after solid-organ transplantation. Clin. Infect. Dis.33(Suppl. 1), S32–S37 (2001).
   Google Scholar
• Stocchi R, Ward KN, Fanin R, Baccarani M, Apperley JF. Management of human cytomegalovirus infection and disease after allogeneic bone marrow transplantation. Haematologica84, 71–79 (1998).
   Google Scholar
• Ljungman P, Perez-Bercoff L, Jonsson J et al. Risk factors for the development of cytomegalovirus disease after allogeneic stem cell transplantation. Haematologica91(1), 78–83 (2006).
   PubMed Web of Science ®Google Scholar
• Einsele B, Ehninger G, Hebart H et al. Polymerase chain reaction monitoring reduces the indicence of cytomegalovirus disease and the duration and side effects of antiviral therapy after bone marrow transplantation. Blood86(7), 2815–2920 (1995).
   PubMed Web of Science ®Google Scholar
• Nichols WG, Corey L, Gooley T. Rising pp65 antigenaemia during preemptive anticytomegalovirus therapy after allogeneic hematopoietic stem cell transplantation: risk factors, correlation with DNA load, and outcomes. Blood97(4), 867–874 (2001).
   PubMed Web of Science ®Google Scholar
• Meyers JD, Ljungman P, Fisher LD. Cytomegalovirus excretion as a predictor of cytomegalovirus disease after marrow transplantation: importance of cytomegalovirus viraemia. J. Infect. Dis.162, 373–380 (1990).
   PubMed Web of Science ®Google Scholar
• Palella FJ, Delaney KM, Moorman AC et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. N. Engl. J. Med.228(13), 853–860 (1998).
   Google Scholar
• Springer KL, Weinberg A. Cytomegalovirus infection in the era of HAART: fewer reactivations and more immunity. J. Antimicrob. Chemother.54(3), 582–586 (2004).
   PubMed Web of Science ®Google Scholar
• Griffiths P. Cytomegalovirus infection of the central nervous system. Herpes11(Suppl. 2), 95A–104A (2004).
   Google Scholar
• Burny W, Liesnard C, Donner C, Marchant A. Epidemiology, pathogenesis and prevention of congenital cytomegalovirus infection. Expert Rev. Anti Infect. Ther.2(6), 881–894 (2004).
   PubMedGoogle Scholar
• Halwachs-Baumann G, Genser B. Die konnatale Zytomegalievirusinfection. Epidemiologie–Diagnose–Therapie. Springer Verlag Wien, NY, USA (2003).
   Google Scholar
• Nigro G, Adler SP, La Torre R, Best AM. Passive immunization during pregnancy for congenital cytomegalovirus infection. N. Engl. J. Med.353(13), 1350–1362 (2005).
   PubMed Web of Science ®Google Scholar
• Kimberlin DW, Lin CY, Sanchez PJ et al. Effect of ganciclovir therapy on hearing in symptomatic congenital cytomegalovirus disease involving the central nervous system: a randomized, controlled trial. J. Pediatr.143(1), 16–25 (2003).
   PubMed Web of Science ®Google Scholar
• Booth JC, Hannington G, Bakir TM et al. Comparison of enzyme-linked immunosorbent assay, radioimmunoassay, complement fixation, anticomplement immunofluorescence and passive haemagglutination techniques for detecting cytomegalovirus IgG antibody. J. Clin. Pathol.35, 1345–1348 (1982).
   PubMed Web of Science ®Google Scholar
• Grint PC, Ronalds CJ, Kangro HO et al. Screening tests for antibodies to cytomegalovirus: an evaluation of five commercial products. J. Clin. Pathol.76, 309–319 (1985).
   Google Scholar
• Grillner L. Screening of blood donors for cytomegalovirus (CMV) antibodies: an evaluation of different tests. J. Virol. Methods17(1–2), 133–139 (1987).
   PubMed Web of Science ®Google Scholar
• Gutierrez J, Maroto MC. A comparison of two ELISA methods for the investigation of anti-cytomegalovirus IgG antibodies. Microbios90(364–365), 151–154 (1997).
   PubMedGoogle Scholar
• Genser B, Truschnig-Wilders M, Stunzner D, Landini MP, Halwachs-Baumann G. Evaluation of five commercial enzyme immunoassays for the detection of human cytomegalovirus-specific IgM antibodies in the absence of a commercially available gold standard. Clin. Chem. Lab. Med.39(1), 62–70 (2001).
   PubMed Web of Science ®Google Scholar
• Lang D, Vornhagen R, Rothe M, Hinderer W, Sonneborn HH, Plachter B. Cross-reactivity of Epstein–Barr virus-specific immunoglobulin M antibodies with cytomegalovirus antigens containing glycine homopolymers. Clin. Diagn. Lab. Immunol.8(4), 747–756 (2001).
   PubMedGoogle Scholar
• Maine GT, Lazzarotto T, Landini MP. New developments in the diagnosis of maternal and congenital CMV infection. Expert Rev. Mol. Diagn.1(1), 19–29 (2001).
   PubMedGoogle Scholar
• Schoppel K, Schmidt C, Einsele H, Hebart H, Mach M. Kinetics of the antibody response against human cytomegalovirus-specific proteins in allogeneic bone marrow transplant recipients. J. Infect. Dis.178(5), 1233–1243 (1998).
   PubMed Web of Science ®Google Scholar
• Lazzarotto T, Barielli L, Lanari M et al. Congenital cytomegalovirus infection: recent advances in the diagnosis of maternal infection. Hum. Immunol.65, 410–415 (2004).
   PubMed Web of Science ®Google Scholar
• Lazzarotto T, Varani S, Spezzacatena P et al. Maternal IgG avidity and IgM detected by blot as diagnostic tools to identify pregnant women at risk of transmitting cytomegalovirus. Viral Immunol.13(1), 137–141 (2000).
   PubMed Web of Science ®Google Scholar
• Lazzarotto T, Varani S, Spezzacatena P et al. Delayed acquisition of high-avidity anti-cytomegalovirus antibody is correlated with prolonged antigenaemia in solid organ transplant recipients. J. Infect. Dis.178(4), 1145–1149 (1998).
   PubMedGoogle Scholar
• Steininger C, Kundi M, Kletzmayr J, Aberle SW, Popow-Kraupp T. Antibody maturation and viremia after primary cytomegalovirus infection, in immunocompetent patients and kidney-transplant patients. J. Infect. Dis.190(11), 1908–1912 (2004).
   PubMed Web of Science ®Google Scholar
• Razonable RR, Paya CV. Herpesvirus infections in transplant recipients: current challenges in the clinical management of cytomegalovirus and Epstein–Barr virus infection. Herpes10(3), 60–65 (2003).
   PubMedGoogle Scholar
• Humar A, Mazzulli T, Moussa G et al. Clinical utility of cytomegalovirus (CMV) serology testing in high-risk CMV D+/R- transplant recipients. Am. J. Transplant.5, 1065–1070 (2005).
   PubMed Web of Science ®Google Scholar
• Carman B. Molecular techniques should now replace cell culture in diagnostic virology laboratories. Rev. Med. Virol.11(6), 347–349 (2001).
   PubMedGoogle Scholar
• Ogilvie M. Molecular techniques should not now replace cell culture in diagnostic virology laboratories. Rev. Med. Virol.11(6), 351–354 (2001).
   PubMedGoogle Scholar
• Wallace PS. Linkage between the journal and quality control molecular diagnostics (QCMD). J. Clin. Virol.27, 211–212 (2003).
   PubMedGoogle Scholar
• Nye MB, Leman AR, Meyer ME, Menegus MA, Rothber PG. Sequence diversity in the glycoprotein B gene complicates real-time PCR assays for detection and quantification of cytomegalovirus. J. Clin. Microbiol.43(10), 4968–4971 (2005).
   PubMedGoogle Scholar
• Schäfer P, Tenschert W, Schröter M, Gutensohn K, Laufs R. False-positive results of plasma PCR for cytomegalovirus DNA due to delayed sample preparation. J. Clin. Microbiol.38(9), 3249–3253 (2000).
   PubMedGoogle Scholar
• Schäfer P, Tenschert W, Kutensohn K, Laufs R. Minimal effect of delayed sample processing on results of quantitative PCR for cytomegalovirus DNA in leukocytes compared to results of an antigenemia assay. J. Clin. Microbiol.35, 741–744 (1997).
   PubMedGoogle Scholar
• Razonable RR, Brown R, Wilson J et al. The clinical use of various blood compartments for cytomegalovirus (CMV) DNA quantitation in transplant recipients with CMV disease. Transplantation73(6), 968–973 (2002).
   PubMed Web of Science ®Google Scholar
• Razonable RR, Emery VC. Management of CMV infection and disease in transplant patients. Herpes11(3), 77–86 (2004).
   PubMedGoogle Scholar
• Preiksaitis JK, Brennan DC, Fishman J, Allen U. Canadian Society of Transplant Consensus Workshop on cytomegalovirus management in solid organ transplantation final report. Am. J. Transplant.5, 218–227 (2005).
   PubMed Web of Science ®Google Scholar
• Lehto JT, Lemström K, Halme M et al. A prospective study comparing cytomegalovirus antigenaemia, DNAemia and RNAemia tests in guiding pre-emptive therapy in thoracic organ transplant recipients. Transpl. Int.18, 1318–1327 (2005).
   PubMedGoogle Scholar
• Martin-Dávila P, Fortún J, Gutiérrez C et al. Analysis of a quantitative PCR assay for CMV infection in liver transplant recipients: an intent to find the optimal cut-off value. J. Clin. Virol.33, 138–144 (2005).
   PubMedGoogle Scholar
• Gerna G, Lilleri D. Monitoring transplant patients for human cytomegalovirus: diagnostic update. Herpes13(1), 4–11 (2006).
   PubMedGoogle Scholar
• Halwachs-Baumann G, Wilders-Truschnig M, Enzinger G et al. Cytomegalovirus diagnosis in renal and bone marrow transplant recipients: the impact of molecular asays. J. Clin. Virol.20, 49–57 (2001).
   PubMedGoogle Scholar
• Chemaly RF, Yen-Lieberman B, Castilla EA et al. Correlation between viral loads of cytomegalovirus in blood and bronchoalveolar lavage specimens from lung transplant recipients determined by histology and immunohistochemistry. J. Clin. Microbiol.42(5), 2168–2172 (2004).
   PubMedGoogle Scholar
• Chemaly RF, Yen-Lieberman B, Chapman J et al. Clinical utility of cytomegalovirus viral load in bronchoalveolar lavage in lung transplant recipients. Am. J. Transplant.5, 544–548 (2005).
   PubMed Web of Science ®Google Scholar
• Westall GP, Michaelides A, Williams TJ, Snell GI, Kotsimbos TC. Human cytomegalovirus load in plasma and bronchoalveolar lavage fluid: a longitudinal study of lung transplant recipients. J. Infect. Dis.190, 1076–1083 (2004).
   PubMedGoogle Scholar
• Meylan PRA, Zanetti G. Cytomegalovirus load in bronchoalveolar lavage fluid: a clue to the diagnosis of cytomegalovirus pneumonia? J. Infect. Dis.191, 2153 (2005).
   PubMedGoogle Scholar
• Halwachs-Baumann G, Genser B, Pailer S et al. Human cytomegalovirus load in various body fluids of congenitally infected newborns. J. Clin. Virol.25, 81–87 (2002).
   PubMedGoogle Scholar
• Tarrago D, Mateos ML, Avellón A, Pérez-Vázquez MD, Tenorio A. Quantitation of cytomegalovirus DNA in cerebrospinal fluid and serum specimens from AIDS patients using a novel highly sensitive nested competitive PCR and the Cobas Amplicor CMV Monitor. J. Med. Virol.72, 249–256 (2004).
   PubMedGoogle Scholar
• Stanojevic M, Zerjav S, Jevtovic D, Salemovic D, Ranin J. CMV DNA in blood and CSF of HIV infected patients. Virus Res.85, 117–122 (2002).
   PubMedGoogle Scholar
• Kojima T, Watanabe T, Hata K, Shinozaki M, Yokoyama T, Nagawa H. Cytomegalovirus infection in ulcerative colitis. Scand. J. Gastroenterol.41(6), 706–711 (2006).
   PubMed Web of Science ®Google Scholar
• Cottone M, Pietrosi G, Martorana G et al. Prevalence of cytomegalovirus infection in severe refractory ulcerative and Crohn’s colitis. Am. J. Gastroenterol.96(3), 773–773 (2001).
   PubMed Web of Science ®Google Scholar
• Wada Y, Matsui T, Matake H et al. Intractable ulcerative colitis caused by cytomegalovirus infection: a prospective study on prevalence, diagnosis, and treatment. Dis. Colon Rectum46(10 Suppl.), S59–S65 (2003).
   Web of Science ®Google Scholar
• Wilson IG. Inhibition and facilitation of nucleic acid amplification. Appl. Environ. Microbiol.63, 3741–3751 (1997).
   PubMed Web of Science ®Google Scholar
• Boom R, Sol C, Weel J et al. Detection and quantitation of human cytomegalovirus DNA in faeces. J. Virol. Methods84, 1–14 (2000).
   PubMed Web of Science ®Google Scholar
• Keightley MC, Rinaldo C, Bullotta A, Dauber J, St George K. Clinical utility of CMV early and late transcript detection with NASBA in bronchoalveolar lavages. J. Clin. Virol.37, 258–264 (2006).
   PubMedGoogle Scholar
• Mengoli C, Cusinato R, Biasolo MA, Cesaro S, Parolin C, Palù G. Assessment of CMV load in solid organ transplant recipients by pp56 antigenaemia and real-time quantitative DNA PCR assay: correlation with pp67 RNA detection. J. Med. Virol.74, 78–84 (2004).
   PubMedGoogle Scholar
• Szczepura A, Wetmoreland D, Vinogradova Y, Fox J, Clark M. Evaluation of molecular techniques in prediction and diagnosis of cytomegalovirus disease in immunocompromised patients. Health Technol. Assess.10(10), 1–176 (2006).
   PubMedGoogle Scholar
• Razonable RR, Paya CV, Smith TF. Role of the laboratory in diagnosis and management of cytomegalovirus infection in hematopoietic stem cell and solid-organ transplant recipients. J. Clin. Microbiol.40(3), 746–752 (2002).
   PubMed Web of Science ®Google Scholar
• Gilbert C, Boivin G. Discordant phenotypes and genotypes of cytomegalovirus (CMV) in patients with AIDS and relapsing CMV retinitis. AIDS17, 337–341 (2003).
   PubMedGoogle Scholar
• Scott GM, Isaacs MA, Zeng F, Kesson AM, Rawlinson WD. Cytomegalovirus antiviral resistance associated with treatment induced UL97 (protein kinase) and UL54 (DNA polymerase) mutations. J. Med. Virol.74, 85–93 (2004).
   PubMedGoogle Scholar
• Gerna G, Percivalle E, Torsellini M, Revello MG. Standardization of the human cytomegalovirus antigenaemia assay by means of in vitro-generated pp65-positive peripheral blood polymorphonuclear leukocytes. J. Clin. Microbiol.36, 3585–3589 (1998).
   PubMedGoogle Scholar
• St George K, Boyd MJ, Lipson SM et al. A multisite trial comparing two cytomegalovirus (CMV) pp65 antigenaemia test kits, biotest CMV Brite and Bartels/Argene CMV Antigenaemia. J. Clin. Microbiol.38(4), 1430–1433 (2000).
   PubMedGoogle Scholar
• Zweygberg Wirgart B, Claesson K et al. Cytomegalovirus (CMV) DNA amplification from plasma compared with CMV pp65 antigen (ppUL83) detection in leukocytes for early diagnosis of symptomatic CMV infection in kidney transplant patients. Clin. Diagn. Virol.7, 99–110 (1996).
   PubMedGoogle Scholar
• Hernando S, Folueira L, Lumbreras C et al. Comparison of cytomegalovirus viral load measure by real-time PCR with pp65 antigenaemia for the diagnosis of cytomegalovirus disease in solid organ transplant patients. Transplant Proc.37, 4094–4096 (2005).
   PubMedGoogle Scholar
• Herrmann B, Larsson VC, Rubin CJ. Comparison of a duplex quantitative real-time PCR assay and the COBAS Amplicor CMV Monitor Test for detection of cytomegalovirus. J. Clin. Microbiol.42(5), 1909–1914 (2004).
   PubMed Web of Science ®Google Scholar
• Biron KK. Antiviral drugs for cytomegalovirus diseases. Antivir. Res.71(2–3), 154–163 (2006).
   PubMed Web of Science ®Google Scholar
• Jabs DA, Enger C, Forman M, Dunn JP. Incidence of foscarnet resistance and cidofovir resistance in patients treated for cytomegalovirus retinitis. Antimicrob. Agents Chemother.42(9), 2240–2244 (1998).
   PubMed Web of Science ®Google Scholar
• Chou S, Marousek G, Parenti DM et al. Mutation in region III of the DNA polymerase gene conferring foscarnet resistance in cytomegalovirus isolates from 3 subjects receiving prolonged antiviral therapy. J. Infect. Dis.178(2), 526–530 (1998).
   PubMedGoogle Scholar
• Abraham B, Lastere S, Reynes J, Bibollet-Ruche F, Vidal N, Segondy M. Ganciclovir resistance and UL97 gene mutations in cytomegalovirus blood isolates from patients with AIDS treated with ganciclovir. J. Clin. Virol.13, 141–148 (1999).
   PubMedGoogle Scholar
• Gilbert C, Handfield J, Toma E, Lalonde R, Bergeron MG, Boivin G. Emergence and prevalence of cytomegalovirus UL97 mutations associated with ganciclovir resistance in AIDS patients. AIDS12, 125–129 (1998).
   PubMed Web of Science ®Google Scholar
• Lee GC, Lee DG, Choi SM et al. Use of time-saving flow cytometry for rapid determination of resistance of human cytomegalovirus to ganciclovir. J. Clin. Microbiol.43(10), 5003–5008 (2005).
   PubMedGoogle Scholar
• McSharry JJ, Lurain NS, Drusano GL et al. Rapid ganciclovir susceptibility assay using flow cytometry for human cytomegalovirus clinical isolates. Antimicrob. Agents Chemother.42(9), 2326–2331 (1998).
   PubMedGoogle Scholar
• Prix L, Maierl J, Jahn G, Hamprecht K. A simplified assay for screening of drug resistance of cell-associated cytomegalovirus strains. J. Clin. Virol.11(1), 29–37 (1998).
   PubMedGoogle Scholar
• Chou S, Lurain NS, Weinberg A et al. Interstrain variation in the human cytomegalovirus DNA polymerase sequence and its effect on genotypic diagnosis of antiviral drug resistance. Antimicrob. Agents Chemother.43(6), 1500–1502 (1999).
   PubMedGoogle Scholar
• Jabs DA, Martin BK, Ricks MO, Forman MS. Detection of ganciclovir resistance in patients with AIDS and cytomegalovirus retinitis: correlation of genotypic methods with viral phenotype and clinical outcome. J. Infect. Dis.193, 1728–1737 (2006).
   PubMedGoogle Scholar
• Ljungman P. Would monitoring CMV immune responses allow improved control of CMV in stem cell transplant patients. J. Clin. Virol.35, 493–495 (2006).
   PubMedGoogle Scholar
• Harari A, Zimmerli SC, Pantaleo G. Cytomegalovirus (CMV)-specific cellular immune responses. Hum. Immunol.65, 500–506 (2004).
   PubMedGoogle Scholar
• Gratama JW, Cornelissen JJ. Clinical utility of tetramer-based immune monitoring in allogeneic stem cell transplantation. Biodrugs17(5), 325–338 (2003).
   PubMedGoogle Scholar
• Gerna G, Percivalle E, Lilleri D et al. Dendritic-cell infection by human cytomegalovirus is restricted to strains carrying functional UL131–128 genes and mediates efficient viral antigen presentation to CD8+ T cells. J. Gen. Virol.86, 275–284 (2005).
   PubMedGoogle Scholar
• Lozza L, Lilleri D, Percivalle E et al. Simultaneous quantification of human cytomegalovirus (HCMV)-specific CD4+ and CD8+ T cells by a novel method using monocyte-derived HCMV-infected immature dendritic cells. Eur. J. Immunol.35, 1795–1804 (2005).
   PubMed Web of Science ®Google Scholar